Pascale, R.; Gallo, M.; Toschi, A.; Viale, P.; Curti, S.; Giannella, M., Validation and prognostic utility of a definition of uncomplicated Gram-negative bloodstream infection, «CLINICAL MICROBIOLOGY AND INFECTION», 2024, 17, pp. 1 - 3 [Scientific article]
Gatti, Milo; Viale, Pierluigi; Cojutti, Pier Giorgio; Zamparini, Eleonora; De Paolis, Massimiliano; Giannella, Maddalena; Pea, Federico; Tedeschi, Sara, A descriptive case series of the relationship between maintenance of conservative PK/PD efficacy thresholds of dalbavancin over time and clinical outcome in long-term treatment of staphylococcal osteoarticular infections, «INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS», 2023, 61, Article number: 106773 , pp. 1 - 8 [Scientific article]Open Access
Gatti M.; Rinaldi M.; Gaibani P.; Siniscalchi A.; Tonetti T.; Giannella M.; Viale P.; Pea F., A descriptive pharmacokinetic/pharmacodynamic analysis of continuous infusion ceftazidime-avibactam for treating DTR gram-negative infections in a case series of critically ill patients undergoing continuous veno-venous haemodiafiltration (CVVHDF), «JOURNAL OF CRITICAL CARE», 2023, 76, Article number: 154301 , pp. 1 - 6 [Scientific article]Open Access
Gatti, Milo; Pascale, Renato; Cojutti, Pier Giorgio; Rinaldi, Matteo; Ambretti, Simone; Conti, Matteo; Tedeschi, Sara; Giannella, Maddalena; Viale, Pierluigi; Pea, Federico, A descriptive pharmacokinetic/pharmacodynamic analysis of continuous infusion ceftazidime-avibactam in a case series of critically ill renal patients treated for documented carbapenem-resistant Gram-negative bloodstream infections and/or ventilator-associated pneumonia, «INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS», 2023, 61, pp. 1 - 7 [Scientific article]Open Access
Giannella M.; Rinaldi M.; Viale P., Antimicrobial Resistance in Organ Transplant Recipients, «INFECTIOUS DISEASE CLINICS OF NORTH AMERICA», 2023, 37, pp. 515 - 537 [Scientific article]Open Access
Giannella M.; Verardi S.; Karas A.; Abdel Hadi H.; Dupont H.; Soriano A.; Santerre Henriksen A.; Cooper A.; Falcone M., Carbapenem-Resistant Acinetobacter spp Infection in Critically Ill Patients with Limited Treatment Options: A Descriptive Study of Cefiderocol Therapy during the COVID-19 Pandemic, «OPEN FORUM INFECTIOUS DISEASES», 2023, 10, Article number: ofad329 , pp. 329 - 331 [Scientific article]Open Access
Gatti, Milo; Fornaro, Giacomo; Viale, Pierluigi; Pea, Federico; Giannella, Maddalena, Clinical efficacy of renal dosing adjustments of ceftazidime‐avibactam in patients affected by carbapenem‐resistant Gram‐negative infections: a systematic review and meta‐analysis of observational studies, «BRITISH JOURNAL OF CLINICAL PHARMACOLOGY», 2023, 89, pp. 617 - 629 [Scientific article]
Righi E.; Scudeller L.; Mirandola M.; Visentin A.; Mutters N.T.; Meroi M.; Schwabe A.; Erbogasto A.; Vantini G.; Cross E.L.A.; Giannella M.; Guirao X.; Tacconelli E., Colonisation with Extended-Spectrum Cephalosporin-Resistant Enterobacterales and Infection Risk in Surgical Patients: A Systematic Review and Meta-analysis, «INFECTIOUS DISEASES AND THERAPY», 2023, 12, pp. 623 - 636 [Scientific article]Open Access
Rinaldi M.; Campoli C.; Gallo M.; Marzolla D.; Zuppiroli A.; Riccardi R.; Casarini M.; Riccucci D.; Malosso M.; Bonazzetti C.; Pascale R.; Tazza B.; Pasquini Z.; Marconi L.; Curti S.; Giannella M.; Viale P., Comparison between available early antiviral treatments in outpatients with SARS-CoV-2 infection: a real-life study, «BMC INFECTIOUS DISEASES», 2023, 23, Article number: 646 , pp. 1 - 9 [Scientific article]Open Access
Rinaldi, M.; Campoli, C.; Gallo, M.; Marzolla, D.; Zuppiroli, A.; Riccardi, R.; Casarini, M.; Riccucci, D.; Malosso, M.; Bonazzetti, C.; Pascale, R.; Tazza, B.; Pasquini, Z.; Marconi, L.; Curti, S.; Giannella, M.; Viale, P., Comparison between available early antiviral treatments in outpatients with SARS-CoV-2 infection: a real-life study, «BMC INFECTIOUS DISEASES», 2023, 23, Article number: 646 , pp. 1 - 8 [Scientific article]
Gatti, Milo; Rinaldi, Matteo; Bonazzetti, Cecilia; Gaibani, Paolo; Giannella, Maddalena; Viale, Pierluigi; Pea, Federico, Could an optimized joint pharmacokinetic/pharmacodynamic target attainment of continuous infusion ceftazidime-avibactam be a way to avoid the need for combo therapy in the targeted treatment of deep-seated DTR Gram-negative infections?, «ANTIMICROBIAL AGENTS AND CHEMOTHERAPY», 2023, 67, Article number: e0096923 , pp. 1 - 12 [Scientific article]Open Access
Liu, Chun; Cojutti, Pier Giorgio; Giannella, Maddalena; Roberto, Marcello; Casadei, Beatrice; Cristiano, Gianluca; Papayannidis, Cristina; Vianelli, Nicola; Zinzani, Pier Luigi; Viale, Pierluigi; Bonifazi, Francesca; Pea, Federico, Does Cytokine-Release Syndrome Induced by CAR T-Cell Treatment Have an Impact on the Pharmacokinetics of Meropenem and Piperacillin/Tazobactam in Patients with Hematological Malignancies? Findings from an Observational Case-Control Study, «PHARMACEUTICS», 2023, 15, Article number: 1022 , pp. 1 - 13 [Scientific article]Open Access
Gatti, Milo; Rinaldi, Matteo; Potena, Luciano; Salvaterra, Elena; Morelli, Maria Cristina; Giannella, Maddalena; Viale, Pierluigi; Pea, Federico, Does therapeutic drug monitoring (TDM) of trough concentrations suffice for optimizing preemptive therapy with ganciclovir of cytomegalovirus infections in non-renal solid organ transplant recipients?, «TRANSPLANT INFECTIOUS DISEASE», 2023, -, Article number: e14107 , pp. 1 - 8 [Scientific article]Open Access
Pasquini Z.; Toschi A.; Casadei B.; Pellegrini C.; D'Abramo A.; Vita S.; Beccacece A.; Bussini L.; Chionsini M.C.; Dentale N.; Cantiani A.; Lazzarotto T.; Bartoletti M.; Nicastri E.; Zinzani P.; Giannella M.; Viale P., Dual combined antiviral treatment with remdesivir and nirmatrelvir/ritonavir in patients with impaired humoral immunity and persistent SARS-CoV-2 infection, «HEMATOLOGICAL ONCOLOGY», 2023, 41, pp. 904 - 911 [Scientific article]Open Access
Masetti M.; Scuppa M.F.; Aloisio A.; Giovannini L.; Borgese L.; Manno S.; Tazza B.; Pascale R.; Bonazzetti C.; Caroccia N.; Sabatino M.; Spitaleri G.; Viale P.; Giannella M.; Potena L., Effect of a Fourth Dose of mRNA Vaccine and of Immunosuppression in Preventing SARS-CoV-2 Breakthrough Infections in Heart Transplant Patients, «MICROORGANISMS», 2023, 11, Article number: 755 , pp. 1 - 13 [Scientific article]Open Access
